Members of the Association of Clinical Research Organizations have more than doubled in size in the past 10 years
Members of the Association of Clinical Research Organizations (ACRO) have more than doubled in size in the past 10 years and now employ more than 100,000 research professionals worldwide with a global payroll of nearly $6 billion. Over the same period, member company revenues have increased 180% (10.8% CAGR) to an estimated $14.2 billion, or approximately two-thirds of contract biopharmaceutical development spending, demonstrating the strong demand for CRO services by pharmaceutical, biotech and medical device companies.
Other key findings from the member survey include:
Throughout the next month, ACRO will be unveiling a series of case studies that highlight CRO innovation, as well as a video series focusing several of these topics.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.